645 related articles for article (PubMed ID: 30013045)
1. An enhanced CRISPR repressor for targeted mammalian gene regulation.
Yeo NC; Chavez A; Lance-Byrne A; Chan Y; Menn D; Milanova D; Kuo CC; Guo X; Sharma S; Tung A; Cecchi RJ; Tuttle M; Pradhan S; Lim ET; Davidsohn N; Ebrahimkhani MR; Collins JJ; Lewis NE; Kiani S; Church GM
Nat Methods; 2018 Aug; 15(8):611-616. PubMed ID: 30013045
[TBL] [Abstract][Full Text] [Related]
2. An efficient KRAB domain for CRISPRi applications in human cells.
Alerasool N; Segal D; Lee H; Taipale M
Nat Methods; 2020 Nov; 17(11):1093-1096. PubMed ID: 33020655
[TBL] [Abstract][Full Text] [Related]
3. Perturbation of Gene Regulation by Genome Editing.
Yeo NC; Church GM
Methods Mol Biol; 2023; 2594():59-68. PubMed ID: 36264488
[TBL] [Abstract][Full Text] [Related]
4. Covalent linkage of the DNA repair template to the CRISPR-Cas9 nuclease enhances homology-directed repair.
Savic N; Ringnalda FC; Lindsay H; Berk C; Bargsten K; Li Y; Neri D; Robinson MD; Ciaudo C; Hall J; Jinek M; Schwank G
Elife; 2018 May; 7():. PubMed ID: 29809142
[TBL] [Abstract][Full Text] [Related]
5. Specific Gene Silencing in Leptospira biflexa by RNA-Guided Catalytically Inactive Cas9 (dCas9).
Fernandes LGV; Nascimento ALTO
Methods Mol Biol; 2020; 2134():109-122. PubMed ID: 32632863
[TBL] [Abstract][Full Text] [Related]
6. RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors.
Thakore PI; Kwon JB; Nelson CE; Rouse DC; Gemberling MP; Oliver ML; Gersbach CA
Nat Commun; 2018 Apr; 9(1):1674. PubMed ID: 29700298
[TBL] [Abstract][Full Text] [Related]
7. Optical Control of Genome Editing by Photoactivatable Cas9.
Otabe T; Nihongaki Y; Sato M
Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
[TBL] [Abstract][Full Text] [Related]
8. Highly Parallel Profiling of Cas9 Variant Specificity.
Schmid-Burgk JL; Gao L; Li D; Gardner Z; Strecker J; Lash B; Zhang F
Mol Cell; 2020 May; 78(4):794-800.e8. PubMed ID: 32187529
[TBL] [Abstract][Full Text] [Related]
9. Rational Design of Mini-Cas9 for Transcriptional Activation.
Ma D; Peng S; Huang W; Cai Z; Xie Z
ACS Synth Biol; 2018 Apr; 7(4):978-985. PubMed ID: 29562138
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 to Silence Long Non-Coding RNAs.
Rosenlund IA; Calin GA; Dragomir MP; Knutsen E
Methods Mol Biol; 2021; 2348():175-187. PubMed ID: 34160807
[TBL] [Abstract][Full Text] [Related]
11. Using an Inducible CRISPR-dCas9-KRAB Effector System to Dissect Transcriptional Regulation in Human Embryonic Stem Cells.
Parsi KM; Hennessy E; Kearns N; Maehr R
Methods Mol Biol; 2017; 1507():221-233. PubMed ID: 27832543
[TBL] [Abstract][Full Text] [Related]
12. High-Performance Allosteric Conditional Guide RNAs for Mammalian Cell-Selective Regulation of CRISPR/Cas.
Hochrein LM; Li H; Pierce NA
ACS Synth Biol; 2021 May; 10(5):964-971. PubMed ID: 33930275
[TBL] [Abstract][Full Text] [Related]
13. Tuning the Expression of Long Noncoding RNA Loci with CRISPR Interference.
Stojic L
Methods Mol Biol; 2020; 2161():1-16. PubMed ID: 32681501
[TBL] [Abstract][Full Text] [Related]
14. Gene silencing based on RNA-guided catalytically inactive Cas9 (dCas9): a new tool for genetic engineering in Leptospira.
Fernandes LGV; Guaman LP; Vasconcellos SA; Heinemann MB; Picardeau M; Nascimento ALTO
Sci Rep; 2019 Feb; 9(1):1839. PubMed ID: 30755626
[TBL] [Abstract][Full Text] [Related]
15. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
Liu Q; Zhang H; Huang X
FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
[TBL] [Abstract][Full Text] [Related]
16. Precise Regulation of Cas9-Mediated Genome Engineering by Anti-CRISPR-Based Inducible CRISPR Controllers.
Jain S; Xun G; Abesteh S; Ho S; Lingamaneni M; Martin TA; Tasan I; Yang C; Zhao H
ACS Synth Biol; 2021 Jun; 10(6):1320-1327. PubMed ID: 34006094
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of active transcriptional repressor domain for CRISPRi in plants.
Xu L; Sun B; Liu S; Gao X; Zhou H; Li F; Li Y
Gene; 2023 Jan; 851():146967. PubMed ID: 36261092
[TBL] [Abstract][Full Text] [Related]
18. Cutting back malaria: CRISPR/Cas9 genome editing of Plasmodium.
Lee MCS; Lindner SE; Lopez-Rubio JJ; Llinás M
Brief Funct Genomics; 2019 Sep; 18(5):281-289. PubMed ID: 31365053
[TBL] [Abstract][Full Text] [Related]
19. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing.
Sandoval IM; Collier TJ; Manfredsson FP
Methods Mol Biol; 2019; 1937():29-45. PubMed ID: 30706388
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9 in genome editing: Its function and medical applications.
Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
